US 8242170
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
granted A61KA61K31/185A61K31/336
Quick answer
US patent 8242170 (Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy) held by The Regents of the University of California expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/185, A61K31/336, A61K45/06, A61P